These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1666659

  • 1. Pharmacokinetics of an etoposide infused over three days: concomitant infusion with cisplatin.
    Minami H, Horio Y, Sakai S, Saka H, Shimokata K.
    Jpn J Clin Oncol; 1991 Dec; 21(6):400-5. PubMed ID: 1666659
    [Abstract] [Full Text] [Related]

  • 2. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D, Boddy A, Thomas H, Lind M, Newell D, Calvert AH, Robson L, Brampton M, Abrahamsen D, Winograd B.
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA, Rosner GL, Ratain MJ, Hollis DR, Green MR, Schilsky RL.
    Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
    [Abstract] [Full Text] [Related]

  • 4. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
    Lokich J, Anderson N, Moore C, Bern M, Coco F, Dow E, Zipoli T, Gonzalves L.
    J Infus Chemother; 1996 May; 6(1):43-6. PubMed ID: 8748007
    [Abstract] [Full Text] [Related]

  • 5. [Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer].
    Sugita T, Matsunaga K, Kobayashi H, Horikawa S, Suzuki Y, Nishiyama H, Maekawa N, Matsumoto H, Okazaki M, Katagami N.
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2479-83. PubMed ID: 7944494
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 7. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
    Bunn PA, Kelly K.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 13. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study.
    Bunn PA, Kelly KL.
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):54-8; discussion 59-60. PubMed ID: 7481862
    [Abstract] [Full Text] [Related]

  • 14. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Honda R, Nishiwaki Y, Hino M, Hayashibe A, Yano H, Kitaya T, Matsuyama T.
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2965-9. PubMed ID: 3021067
    [Abstract] [Full Text] [Related]

  • 15. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW, Radiation Therapy Oncology Group 9609.
    J Clin Oncol; 2005 Aug 01; 23(22):4991-8. PubMed ID: 15939930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
    Chewaskulyong B, Thongprasert S.
    J Med Assoc Thai; 1998 Jan 01; 81(1):37-41. PubMed ID: 9470320
    [Abstract] [Full Text] [Related]

  • 18. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
    Yanagawa H, Bando H, Takishita Y.
    Anticancer Res; 1995 Jan 01; 15(2):613-6. PubMed ID: 7539241
    [Abstract] [Full Text] [Related]

  • 19. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
    You B, Tranchand B, Girard P, Falandry C, Ribba B, Chabaud S, Souquet PJ, Court-Fortune I, Trillet-Lenoir V, Fournel C, Tod M, Freyer G.
    Lung Cancer; 2008 Nov 01; 62(2):261-72. PubMed ID: 18442869
    [Abstract] [Full Text] [Related]

  • 20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Nov 01; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.